Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 - Chen, Xiangyu; Pan, Zhiwei; Yue, Shuai; Yu, Fei; Zhang, Junsong; Yang, Yang; Li, Ren; Liu, Bingfeng; Yang, Xiaofan; Gao, Leiqiong; Li, Zhirong; Lin, Yao; et al. (Signal transduction and targeted therapy, 2020)
Keywords: 631/250/2152; 631/250/255; Adult; Antibodies, Neutralizing - biosynthesis; Antibodies, Viral - biosynthesis; Asymptomatic; Betacoronavirus - immunology; Betacoronavirus - pathogenicity; Cancer Research; Case-Control Studies; Cell Biology; Convalescence; Coronavirus Infections - blood; Coronavirus Infections - immunology; Coronavirus Infections - pathology; Coronavirus Infections - virology; Coronaviruses; COVID-19; Female; Humans; Internal Medicine; Male; Medicine; Medicine & Public Health; Middle Aged; Neutralization Tests; Oncology; Pandemics; Pathology; Pneumonia, Viral - blood; Pneumonia, Viral - immunology; Pneumonia, Viral - pathology; Pneumonia, Viral - virology; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Severity of Illness Index